Loading…
Lobbying Spend
—
Filings
10
Firms Hired
1
Active Period
2024–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 1, One Big Beautiful Bill Act implementation of ORPHAN CURES Act, Transitional coverage for innovative medical devices (Ensuring Patient Access to Critical Breakthrough Products Act), IRA implementation of drug pricing provisions, Oppose proposed changes to the Medicaid Drug Rebate Program, Medicare coverage for anti-obesity medication and multi-cancer screening tests.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 1, One Big Beautiful Bill Act, issues related to R&D tax credit. Monitor trade and tariff issues related to pharmaceutical tariffs. Health care IP.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 1, One Big Beautiful Bill Act, issues related to R&D tax credit. Monitor trade and tariff issues related to pharmaceutical tariffs. Health care IP.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 1, One Big Beautiful Bill Act implementation of ORPHAN CURES Act, Transitional coverage for innovative medical devices (Ensuring Patient Access to Critical Breakthrough Products Act), IRA implementation of drug pricing provisions, Oppose proposed changes to the Medicaid Drug Rebate Program, Medicare coverage for anti-obesity medication and multi-cancer screening tests.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 1, One Big Beautiful Bill Act, issues related to R&D tax credit. Monitor trade and tariff issues related to pharmaceutical tariffs. Health care IP.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 1, One Big Beautiful Bill Act implementation of ORPHAN CURES Act, Transitional coverage for innovative medical devices (Ensuring Patient Access to Critical Breakthrough Products Act), IRA implementation of drug pricing provisions, Oppose proposed changes to the Medicaid Drug Rebate Program, Medicare coverage for anti-obesity medication and multi-cancer screening tests.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 1, One Big Beautiful Bill Act implementation of ORPHAN CURES Act, Transitional coverage for innovative medical devices (Ensuring Patient Access to Critical Breakthrough Products Act), IRA implementation of drug pricing provisions, Oppose proposed changes to the Medicaid Drug Rebate Program, Medicare coverage for anti-obesity medication and multi-cancer screening tests.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 1, One Big Beautiful Bill Act, issues related to R&D tax credit. Monitor trade and tariff issues related to pharmaceutical tariffs. Health care IP.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 1, One Big Beautiful Bill Act, issues related to R&D tax credit. Monitor trade and tariff issues related to pharmaceutical tariffs. Health care IP.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 1, One Big Beautiful Bill Act implementation of ORPHAN CURES Act, Transitional coverage for innovative medical devices (Ensuring Patient Access to Critical Breakthrough Products Act), IRA implementation of drug pricing provisions, Oppose proposed changes to the Medicaid Drug Rebate Program, Medicare coverage for anti-obesity medication and multi-cancer screening tests.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 1, One Big Beautiful Bill Act, issues related to R&D tax credit. Monitor trade and tariff issues related to pharmaceutical tariffs.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug priing issues, particularly related to MFN.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1
Source: Senate LDA